Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
Xiang Zheng(Novo Nordisk Foundation), Zailong Qin(Guangxi Maternal and Child Health Hospital), Lujuan Wang(Central South University), Lili Huang(Chongqing Medical University), Xuemei Zhang(Weifang Medical University), Jia Wang(Changzhi Medical College), Peng Qiu(Central South University)
Cited by 133
Related Papers
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|Molecular Therapy|2013|624
Fen1 mutations result in autoimmunity, chronic inflammation and cancers
|Nature Medicine|2007|249
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
|Journal of Innate Immunity|2017|122
MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer
|Cancer Letters|2017|120
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications
|Journal of Hematology & Oncology|2025|120